Merck & Co., Inc  NYSE:MRK

Company

First Coverage

Logo
Merck & Co., Inc NYSE:MRK

$ 60

12-May-15

Report Date Price
International Equities: NYSE 12-May-15 $60

Overview

For 130 years, Merck & Co., Inc (known as MSD outside of the U.S. and Canada) has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of their mission to save and improve lives.

They demonstrate their commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships.

Today, Merck & Co., Inc continue to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases, such as HIV and Ebola, and emerging animal diseases.

Merck is a leading global biopharmaceutical company that has been inventing for life for more than a century, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate in more than 140 countries to deliver innovative health solutions. They also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world – including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola.